A general purpose RNA-cleaving DNA enzyme
- PMID: 9113977
- PMCID: PMC20710
- DOI: 10.1073/pnas.94.9.4262
A general purpose RNA-cleaving DNA enzyme
Abstract
An in vitro selection procedure was used to develop a DNA enzyme that can be made to cleave almost any _targeted RNA substrate under simulated physiological conditions. The enzyme is comprised of a catalytic domain of 15 deoxynucleotides, flanked by two substrate-recognition domains of seven to eight deoxynucleotides each. The RNA substrate is bound through Watson-Crick base pairing and is cleaved at a particular phosphodiester located between an unpaired purine and a paired pyrimidine residue. Despite its small size, the DNA enzyme has a catalytic efficiency (kcat/Km) of approximately 10(9) M-1.min-1 under multiple turnover conditions, exceeding that of any other known nucleic acid enzyme. Its activity is dependent on the presence of Mg2+ ion. By changing the sequence of the substrate-recognition domains, the DNA enzyme can be made to _target different RNA substrates. In this study, for example, it was directed to cleave synthetic RNAs corresponding to the start codon region of HIV-1 gag/pol, env, vpr, tat, and nef mRNAs.
Figures
Similar articles
-
Mechanism and utility of an RNA-cleaving DNA enzyme.Biochemistry. 1998 Sep 22;37(38):13330-42. doi: 10.1021/bi9812221. Biochemistry. 1998. PMID: 9748341
-
The influence of arm length asymmetry and base substitution on the activity of the 10-23 DNA enzyme.Antisense Nucleic Acid Drug Dev. 2000 Oct;10(5):323-32. doi: 10.1089/oli.1.2000.10.323. Antisense Nucleic Acid Drug Dev. 2000. PMID: 11079572
-
Potent inhibition of HIV-1 gene expression and TAT-mediated apoptosis in human T cells by novel mono- and multi_target anti-TAT/Rev/Env ribozymes and a general purpose RNA-cleaving DNA-enzyme.Antiviral Res. 2006 Nov;72(2):134-44. doi: 10.1016/j.antiviral.2006.05.009. Epub 2006 Jun 8. Antiviral Res. 2006. PMID: 16790281
-
In vitro selection, characterization, and application of deoxyribozymes that cleave RNA.Nucleic Acids Res. 2005 Nov 11;33(19):6151-63. doi: 10.1093/nar/gki930. Print 2005. Nucleic Acids Res. 2005. PMID: 16286368 Free PMC article. Review.
-
Suppression of gene expression by _targeted disruption of messenger RNA: available options and current strategies.Stem Cells. 2000;18(5):307-19. doi: 10.1634/stemcells.18-5-307. Stem Cells. 2000. PMID: 11007915 Review.
Cited by
-
DNA Catalysis: Design, Function, and Optimization.Molecules. 2024 Oct 23;29(21):5011. doi: 10.3390/molecules29215011. Molecules. 2024. PMID: 39519652 Free PMC article. Review.
-
Cross-chiral exponential amplification of an RNA enzyme.Proc Natl Acad Sci U S A. 2024 Oct 29;121(44):e2413668121. doi: 10.1073/pnas.2413668121. Epub 2024 Oct 22. Proc Natl Acad Sci U S A. 2024. PMID: 39436654
-
On-demand controlled bidirectional DNAzyme path for ultra-sensitive heavy metal ion detection.Chem Sci. 2024 Oct 11;15(43):18170-8. doi: 10.1039/d4sc04404e. Online ahead of print. Chem Sci. 2024. PMID: 39421206 Free PMC article.
-
Recent Advances and Prospects of Nucleic Acid Therapeutics for Anti-Cancer Therapy.Molecules. 2024 Oct 7;29(19):4737. doi: 10.3390/molecules29194737. Molecules. 2024. PMID: 39407665 Free PMC article. Review.
-
Using nucleolytic toxins as restriction enzymes enables new RNA applications.Nucleic Acids Res. 2024 Oct 14;52(18):e90. doi: 10.1093/nar/gkae779. Nucleic Acids Res. 2024. PMID: 39271118 Free PMC article.
References
-
- Kruger K, Grabowski P J, Zaug A J, Sands J, Gottschling D E, Cech T R. Cell. 1982;31:147–157. - PubMed
-
- Guerrier-Takada C, Gardiner K, Marsh T, Pace N, Altman S. Cell. 1983;35:849–857. - PubMed
-
- Herschlag D, Cech T R. Biochemistry. 1990;29:10159–10171. - PubMed
-
- Breaker R R, Joyce G F. Chem Biol. 1994;1:223–229. - PubMed
-
- Cuenoud B, Szostak J W. Nature (London) 1995;375:611–614. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous